SLN Stock Analysis: Buy, Sell, or Hold?
SLN - Silence Therapeutics Plc American Depository Share
$13.27
0.10 (0.76%)
▲
5d:
-3.28%
30d:
+15.9%
90d:
+104.47%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When SLN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: SLN shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: SLN shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: SLN is currently trading at $13.27, which is considered extended relative to its 30-day fair value range of $10.14 to $13.40.
Technical Outlook: Technically, SLN is in a strong uptrend. The price is currently testing key support at $13.01. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SLN scores 8/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $33.00 (+150.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SLN is in a strong uptrend. The price is currently testing key support at $13.01. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SLN scores 8/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $33.00 (+150.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$10.14 -
$13.40
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.3%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (8/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 150.6% below Wall St target ($33.00)
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$10.14 -
$13.40
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$13.01
Resistance Level
$17.58
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-17.22
Wall Street Target
$33.00
(+150.6%)
Revenue Growth (YoY)
197.2%
Share & Embed Analysis
Last updated: August 24, 2026 2:51 AM ET
Data refreshes hourly during market hours. Next update: 3:51 AM
Data refreshes hourly during market hours. Next update: 3:51 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 42 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 66 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 50 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$108 | 52 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$138 | 66 BUY |
